1mg vs PharmEasy vs Apollo 24/7: Price Data Study 2026
Introduction Actowiz tracked 10,000+ OTC, wellness, and healthcare-product SKUs across Tata 1mg, PharmEasy, and Apollo 24/7 for 60 days. Findings: advertised discount depth averaged 28% / 34% / 14% respectively but converged sharply after membership and coupon normalization; availability — not price — was the real differentiator, with Tata 1mg holding the best in-stock rate (48%) on monitored SKUs; and pincode-level delivery promises diverged by up to 2 days between metros and tier-2 towns. this analysis covers publicly listed prices and availability of OTC and wellness products for market-intelligence purposes. It is not medical guidance, and no prescription-medicine purchasing analysis is included. Why E-Pharmacy Data, Why Now India's e-pharmacy market consolidated into three serious platforms, each with a different parent strategy: Tata's ecosystem play (1mg), PharmEasy's diagnostics-plus-delivery stack, and Apollo's omnichannel hospital-pharmacy network. Their pri...